Amarantus Bio International Convention Presentatio
Post# of 30066
Posted On: 06/19/2015 10:37:05 PM
Amarantus Bio International Convention Presentation Cliffs Notes -
Eltoprazine - 8:39 "Building up the portfolio and dataset around the PD program to create more value and to bring other bidders to the table."
ESS - 16:20 "In the process of now of completing this acquisition and we expect it to be completed very shortly and then we'll be taking over Phase II clinical study that's starting in July."
AMDX - 17:14 "We are in the process of now evaluating sale, co-development for one or part of the assets or an IPO . Ravi Kiron is here. He's meeting with pharmaceutical companies to review the opportunity."
Uplisting - 17:34 - "We have cash to carry us through. We are in the process now of preparing for a NASDAQ uplisting. We recently completed are capital restructuring to that end and we are hoping to get that done over the Summer ."
Strategic Transaction - 18:39 "This year we expect to have a strategic transaction completed in our diagnostic division for one or more of the assets as well as monetization capabilities for the parent company.
http://www.veracast.com/webcasts/bio/internat...439959.cfm
Eltoprazine - 8:39 "Building up the portfolio and dataset around the PD program to create more value and to bring other bidders to the table."
ESS - 16:20 "In the process of now of completing this acquisition and we expect it to be completed very shortly and then we'll be taking over Phase II clinical study that's starting in July."
AMDX - 17:14 "We are in the process of now evaluating sale, co-development for one or part of the assets or an IPO . Ravi Kiron is here. He's meeting with pharmaceutical companies to review the opportunity."
Uplisting - 17:34 - "We have cash to carry us through. We are in the process now of preparing for a NASDAQ uplisting. We recently completed are capital restructuring to that end and we are hoping to get that done over the Summer ."
Strategic Transaction - 18:39 "This year we expect to have a strategic transaction completed in our diagnostic division for one or more of the assets as well as monetization capabilities for the parent company.
http://www.veracast.com/webcasts/bio/internat...439959.cfm
(0)
(0)